https://biotechmorning.com/news/csl-amazon-aws-ai-drug-pipeline Biotech Morning en 2026-10-07T14:18:09.361Z CSL Just Handed Its Drug Pipeline to Amazon's Cloud https://biotechmorning.com/news/astrazeneca-billion-dollar-kendall-square-rd-hub Biotech Morning en 2026-10-07T14:17:23.194Z AstraZeneca Just Dropped $1 Billion on a Single Zip Code https://biotechmorning.com/news/arrivent-lung-cancer-trial-failure Biotech Morning en 2026-10-07T14:16:46.644Z The Lung Cancer Drug That Fell 1.5 Months Short of Mattering https://biotechmorning.com/news/caribou-biosciences-shuts-down-crispr-car-t Biotech Morning en 2026-10-07T14:16:00.927Z The Nobel Laureate's CRISPR Company Just Pulled the Plug https://biotechmorning.com/news/trex-bio-ipo-lilly-backed Biotech Morning en 2026-10-07T14:15:15.515Z Lilly's Favorite Pet Dinosaur Just Hit the Public Markets https://biotechmorning.com/news/boehringer-leo-pharma-spevigo-il36-deal Biotech Morning en 2026-10-07T14:14:30.369Z Why Boehringer Just Handed Its Skin Drug to a Rival https://biotechmorning.com/news/sarepta-black-box-warning-layoffs-gene-therapy-crisis-2 Biotech Morning en 2026-10-07T14:13:46.028Z Sarepta's Worst Week: A Black Box, 500 Pink Slips, and a Gene Therapy Identity Crisis https://biotechmorning.com/news/nobel-prize-mirror-image-molecules-drug-development Biotech Morning en 2026-10-07T14:12:59.360Z The Nobel Prize That Explains Why Your Medication Only Works One Way https://biotechmorning.com/news/fayuvi-gene-therapy-3-95-million-price Biotech Morning en 2026-10-07T14:12:16.210Z The $3.95 Million Drug That Costs More Than Most Houses https://biotechmorning.com/news/eli-lilly-beat-its-own-zepbound-obesity-drug Biotech Morning en 2026-10-07T14:11:31.297Z Eli Lilly Just Beat Its Own Best-Selling Drug. On Purpose. https://biotechmorning.com/news/oral-infigratinib-achondroplasia-fda-priority-review Biotech Morning en 2026-10-06T14:16:21.452Z The Pill That Could Replace Your Kid's Daily Shot https://biotechmorning.com/news/csl-alentis-claudin-1-deal Biotech Morning en 2026-10-06T14:15:39.360Z CSL Just Bet $1.6 Billion on a Protein Nobody's Heard Of https://biotechmorning.com/news/sarepta-elevidys-gene-therapy-fda-investigation-deaths Biotech Morning en 2026-10-06T14:14:54.967Z The Gene Therapy That Was Supposed to Be a Miracle https://biotechmorning.com/news/novartis-abogen-mRNA-deal Biotech Morning en 2026-10-06T14:14:11.982Z Novartis Just Bet $7.8 Billion That mRNA Can Do Way More Than Vaccines https://biotechmorning.com/news/nobel-prize-optogenetics-brain-light Biotech Morning en 2026-10-06T14:13:24.868Z The Nobel Prize Just Went to Scientists Who Learned to Control the Brain With Light https://biotechmorning.com/news/fda-public-input-ibogaine-trial-design Biotech Morning en 2026-10-06T14:12:36.150Z The FDA Just Asked the Internet to Help Design a Drug Trial https://biotechmorning.com/news/forbion-2-3-billion-european-biotech-fund Biotech Morning en 2026-10-06T14:11:52.090Z Europe's Biggest Biotech Bet Just Got a Lot Bigger https://biotechmorning.com/news/fda-clears-app-treat-schizophrenia-negative-symptoms Biotech Morning en 2026-10-06T14:11:11.262Z The FDA Just Cleared a Phone App to Treat Schizophrenia. Seriously. https://biotechmorning.com/news/shionogi-intrabio-2-billion-rare-disease-acquisition Biotech Morning en 2026-10-06T14:10:21.153Z Why Shionogi Just Bet $2 Billion on a Tiny Texas Biotech https://biotechmorning.com/news/epcoritamab-frontline-dlbcl-phase-3-results Biotech Morning en 2026-10-06T14:09:35.397Z The Drug That Could Rewrite How We Treat the Most Common Blood Cancer https://biotechmorning.com/news/astrazeneca-2-billion-summit-therapeutics-ivonescimab-2 Biotech Morning en 2026-10-06T14:08:51.885Z AstraZeneca Just Bet $2 Billion on a Drug It Doesn't Even Own